Chugai   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tokyo Japan (1943)
Status: Acquired by Roche (2014)

Organization Overview

First Clinical Trial
1999
NCT00247663
First Marketed Drug
1997
tocilizumab (actemra)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chugai Pharmaceutical | Chugai Pharmaceutical,Clinical Research Department 2 | Chugai Pharmaceutical Co., Ltd. Research Dept.1 | Chugai Pharmaceuticals | Chugai Pharma China | Chugai Pharma Europe Ltd. | Chugai Pharma France | Chugai Pharma GmbH | Chugai Pharma Taiwan | Chugai Pharma UK Limited | Chugai Pharma USA | CHUGAI sanofi-aventis | Clinical Research Department 4, Chugai Pharmaceutical Co., Ltd. | clinical-trials@chugai-pharm.co.jp